Feature | ASTRO | August 29, 2019

Top Radiation Oncology Research and Clinical Trials at ASTRO 2019

ASTRO highlights top-rated abstract presentations at its annual meeting

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart. #ASTRO19 #ASTRO2019 #ASTRO

An example of a treatment plan for radio-ablation of the heart to noninvasively treat cardiac arrhythmias. This concept is one of the key presentations at the 2019 ASTRO meeting. Image courtesy of Cyberheart.

August 29, 2019 — The American Society for Radiation Oncology (ASTRO) announced the top-rated studies being highlighted at the 2019 ASTRO Annual Meeting, Sept. 15 - 18 in Chicago. These presentations are being highlighted with press conferences.

Presentations Sunday, Sept. 15:

   • Two Years of Anti-Androgen Treatment Increases Other-Cause Mortality in Men Receiving Early Salvage Radiotherapy: A Secondary Analysis of the NRG Oncology/RTOG 9601 Randomized Phase III Trial, presented by Daniel Spratt, University of Michigan Rogel Cancer Center (Abstract LBA-1)

   • Primary Outcomes of a Phase II Randomized Trial of Observation versus Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer (ORIOLE), presented by  Ryan Phillips, Johns Hopkins Kimmel Cancer Center (Abstract LBA-3)

   • Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial, presented by Julia White, The Ohio State University Comprehensive Cancer Center (Abstract 5)

   • Longer Term Results from a Phase I/II Study of EP-guided Noninvasive Cardiac Radioablation for Treatment of Ventricular Tachycardia (ENCORE-VT)," presented by  Clifford Robinson, Washington University School of Medicine in St. Louis (Abstract LBA-4)

Presentations Monday, Sept. 16:

   • Final Results of a Phase II Prospective Trial Evaluating the Combination of Stereotactic Body Radiotherapy (SBRT) with Concurrent Pembrolizumab in Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC), presented by Allison Campbell, Yale Cancer Center (Abstract 74)

   • Patterns of Disease Progression with Durvalumab in Stage III NSCLC (PACIFIC), presented by Andreas Rimner, Memorial Sloan Kettering Cancer Center (Abstract LBA-6)

   • Applying a Machine Learning Approach to Predict Acute Radiation Toxicities for Head and Neck Cancer Patients, presented by Jay P. Reddy, The University of Texas MD Anderson Cancer Center (Abstract 141)

   • The Impact of the Closure of Women’s Health Clinics on Cervical Cancer in the United States, presented by Amar Srivastava, Washington University School of Medicine in St. Louis (Abstract 202)

The 2019 ASTRO Annual Meeting is expected to attract more than 10,000 oncologists, clinicians, researchers and other healthcare professionals from across the globe. Throughout the four-day meeting, researchers will present peer-reviewed abstracts on advances in clinical care for cancer patients, while panels and interactive case discussions featuring leading experts will underscore the meeting’s theme, “Innovate, Collaborate: Transform.”

Late-breaking Radiation Therapy Clinical Trials at ASTRO 2018

Find more news and video from ASTRO

 

Related Content

Videos | Radiation Oncology | September 20, 2019
Anne Hubbard, MBA, director of health policy for ASTRO, explains the details and purpose of the proposed Radiation On
Densitas Wins Major Procurement of Breast Density Software for DIMASOS Breast Screening Trial
News | Breast Density | September 20, 2019
Densitas Inc. announced it has won a procurement of its densitas densityai software for deployment in up to 24 breast...
Videos | Radiation Therapy | September 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with...
Aktina Showcases New Radiotherapy Patient Immobilization Solutions at ASTRO 2019
News | Patient Positioning Radiation Therapy | September 20, 2019
Aktina Medical introduced several new products at the 2019 American Society for Radiation Oncology (ASTRO) annual...
Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System
News | Proton Therapy | September 20, 2019
Varian announced its ProBeam 360° proton therapy system is now available in a multi-room configuration. The ProBeam 360...
Screening Mammography Could Benefit Men at High Risk of Breast Cancer
News | Mammography | September 18, 2019
Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at...
Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology

Anne Hubbard, MBA, director of health policy for the American Society for Radiation Oncology (ASTRO), explains the details of the proposed radiation oncology alternative payment model (APM), and issues ASTRO has raised with the model, at the 2019 ASTRO annual meeting in Chicago.

News | Radiation Oncology | September 18, 2019
During its annual meeting in September, the American Society for Radiation Oncology (ASTRO) issued a response to the...
Radiation After Immunotherapy Improves Progression-free Survival for Some Metastatic Lung Cancer Patients
News | Lung Cancer | September 18, 2019
Adding precisely aimed, escalated doses of radiation after patients no longer respond to immunotherapy reinvigorates...
IBA Gathers Experts on Flash Irradiation During ASTRO
News | Proton Therapy | September 17, 2019
IBA (Ion Beam Applications SA, held its third Victoria Consortium Meeting focusing on Flash irradiation at the 2019...
Noninvasive Radioablation Offers Long-term Benefits to High-risk Heart Arrhythmia Patients
News | Radiation Therapy | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of...